Morgan Stanley Ionis Pharmaceuticals Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Morgan Stanley holds 1,310,451 shares of IONS stock, worth $39.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,310,451

Previous 1,012,805 29.39%

Holding current value

$39.8 Million

Previous $48.3 Million 8.75%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.06 - $51.86 $11.9 Million - $15.4 Million	297,646 Added 29.39%	1,310,451 $52.5 Million
Q2 2024 Oct 17, 2024	SELL	$36.45 - $47.7 $5.5 Million - $7.19 Million	-150,793 Reduced 12.96%	1,012,805 $48.3 Million
Q2 2024 Aug 14, 2024	SELL	$36.45 - $47.7 $5.5 Million - $7.19 Million	-150,793 Reduced 12.96%	1,012,805 $48.3 Million
Q1 2024 Oct 17, 2024	BUY	$42.03 - $53.55 $6.34 Million - $8.07 Million	150,793 Added 14.89%	1,163,598 $50.4 Million
Q1 2024 Aug 16, 2024	BUY	$42.03 - $53.55 $3.08 Million - $3.93 Million	73,335 Added 6.73%	1,163,598 $50.4 Million
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $3.08 Million - $3.93 Million	73,335 Added 6.73%	1,163,598 $50.4 Million
Q4 2023 Aug 16, 2024	BUY	$43.39 - $51.63 $3.36 Million - $4 Million	77,458 Added 7.65%	1,090,263 $55.2 Million
Q4 2023 Feb 13, 2024	BUY	$43.39 - $51.63 $2.47 Million - $2.94 Million	56,859 Added 5.5%	1,090,263 $55.2 Million
Q3 2023 Nov 15, 2023	SELL	$38.5 - $47.13 $3.68 Million - $4.5 Million	-95,484 Reduced 8.46%	1,033,404 $46.9 Million
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $4.37 Million - $5.45 Million	125,879 Added 12.55%	1,128,888 $46.3 Million
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $2.23 Million - $2.73 Million	66,300 Added 7.08%	1,003,009 $35.8 Million
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $8.92 Million - $11.2 Million	240,171 Added 34.48%	936,709 $35.4 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $1.51 Million - $2.02 Million	-41,439 Reduced 5.62%	696,538 $30.8 Million
Q2 2022 Oct 27, 2022	BUY	$31.71 - $43.0 $6.93 Million - $9.4 Million	218,500 Added 42.06%	737,977 $27.3 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $6.93 Million - $9.4 Million	218,500 Added 42.06%	737,977 $27.3 Million
Q1 2022 Oct 27, 2022	SELL	$29.88 - $37.04 $6.53 Million - $8.09 Million	-218,500 Reduced 29.61%	519,477 $19.2 Million
Q1 2022 May 13, 2022	BUY	$29.88 - $37.04 $1.63 Million - $2.02 Million	54,592 Added 11.74%	519,477 $19.2 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $846,436 - $1.16 Million	-33,051 Reduced 6.64%	464,885 $14.1 Million
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $16.7 Million - $20.2 Million	497,936 New	497,936 $16.7 Million

Others Institutions Holding IONS

# of Institutions

411

Shares Held

139M

Call Options Held

957K

Put Options Held

701K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.31B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account